Miniatura

Fitxers

1-s2.0-S0001731023008475-main.pdf (755.73 KB)

Tipus de document

Article

Data de publicació

2024-03-01

Llicència de publicació

cc by-nc-nd (c) Sánchez Díaz, M. et al, 2024
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/214566

Condicionantes de acceso a nuevos medicamentos dermatológicos en España: resultados del proyecto EQUIDAD

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1016/j.ad.2023.10.016

Resum

Background: Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities (ACs) is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescription requirements for new dermatology drugs across the autonomous communities. Material and methods: Cross-sectional study conducted in April and May, 2023. Two dermatologists with management responsibilities from each autonomous community reported on territorial and more local prescription requirements for drugs covered by national TPRs issued between 2016 and 2022. Results: Thirty-three researchers from 17 autonomous communities participated. The data submitted revealed between-community inequities in access to new drugs. Overall, 64.7% of the regions imposed additional prescription requirements to those mentioned in the TPRs for psoriasis. This percentage was lower for atopic dermatitis (35.3%) and melanoma (11.8%). The most common requirement for accessing a new drug was a previous prescription for another drug. Differences and additional requirements were also detected at the local level (i.e., differences between hospitals within the same autonomous community). Conclusions: Spain's autonomous communities have multiple regional and local prescription requirements that are not aligned with national TPR recommendations. These differences result in inequitable access to new drugs for both patients and practitioners across Spain. (c) 2023 AEDV. Published by Elsevier Espa & nacute;a, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Matèries

Equitat (Dret), Medicaments dermatològics

Matèries (anglès)

Equity, Dermatologic agents

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

SÁNCHEZ DÍAZ, Miguel, FLÓREZ, Á., ARA MARTÍN, M., ARIAS SANTIAGO, S., BOTELLA ESTRADA, R., CAÑUETO, J., CARRETERO HERNÁNDEZ, G., COTO SEGURA, P., DE EUSEBIO MURILLO, E., GARCÍA LATASA DE ARANÍBAR, F.j., GARCÍA-PATOS BRIONES, Vicente, GARDEAZABAL GARCÍA, J., GÓMEZ FERNÁNDEZ, C., HERNÁNDEZ OSTIZ, S., IZU BELLOSO, R., LÓPEZ ÁVILA, A., MANCHADO LÓPEZ, P., MARTÍN SANTIAGO, A., MARTINEZ DE ESPRONCEDA EZQUERRO, I., MATEU PUCHADES, A., MERCADER GARCÍA, P., NOTARIO, Jaime, PALACIO ALLER, L., PÉREZ HORTET, C., QUINTANA CASTANEDO, L., RIVERA, R., ROCAMORA DURAN, V., RODRÍGUEZ NEVADO, I. m., RUIZ VILLAVERDE, Ricardo, SUÁREZ, J., TRASOBARES MARUGÁN, L., VIZÁN DE UÑA, C., YANGUAS, I., ZULAICA GARATE, A., GARCÍA DOVAL, I., DESCALZO, M.á., GRAU PÉREZ, M., CARRASCOSA CARRILLO, J. m.. Condicionantes de acceso a nuevos medicamentos dermatológicos en España: resultados del proyecto EQUIDAD. _Actas Dermo-Sifiliográficas_. 2024. Vol. 115, núm. 3, pàgs. 237-245. [consulta: 7 de febrer de 2026]. ISSN: 1578-2190. [Disponible a: https://hdl.handle.net/2445/214566]

Exportar metadades

JSON - METS

Compartir registre